Products are for professional/laboratory use only. Asthma is a serious respiratory condition affecting both children and adults across Australia and New Zealand. Over 2.5 million (about 1 in 9) Australians have asthma with more children than adults affected. There are over 400 asthma deaths each year in Australia alone.1
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.
The Phadia range of instruments by Thermo Fisher: Phadia 200, Phadia 250, and Phadia 2500, are the only automated systems available that offer both ImmunoCAP Allergy and EliA Autoimmune testing on the one platform.
The Phadia range of instruments: Phadia 200, Phadia 250, and Phadia 2500, are the only automated systems available that offer both ImmunoCAP Allergy and EliA Autoimmune testing on the one platform.
Quality Club is an External Quality Assessment Program for Specific IgE, Total IgE, ECP and EliA Autoimmunity
ImmunoCAP Tryptase is a well-known clinical marker in explaining severe reactions cause by insect venoms, drugs, or in systemic mastocytosis.
Authors: Knut Brockow1 , Lawrence B Schwartz2 1 Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany 2 Department of Internal Medicine, Division of Rheumatology, Allergy & Immunology, Virginia Commonwealth University, Richmond, Virginia, USA
Discover the new ImmunoCAP bee venom components
An allergy diagnosis is based on the history, clinical symptoms and physical examination of the patient in combination with results of sIgE tests.